These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 6096686

  • 21. Protective effects of vaccines against Bordetella parapertussis in a mouse intranasal challenge model.
    Komatsu E, Yamaguchi F, Eguchi M, Watanabe M.
    Vaccine; 2010 Jun 17; 28(27):4362-8. PubMed ID: 20438876
    [Abstract] [Full Text] [Related]

  • 22. Serological correlates in whooping cough.
    Granström M, Granström G.
    Vaccine; 1993 Jun 17; 11(4):445-8. PubMed ID: 8470429
    [Abstract] [Full Text] [Related]

  • 23. Toxicity and potency evaluation of pertussis vaccines.
    Corbel MJ, Xing DK.
    Expert Rev Vaccines; 2004 Feb 17; 3(1):89-101. PubMed ID: 14761246
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Protective immunogenicity of synthetic peptides selected from the amino acid sequence of Bordetella pertussis toxin subunit S1.
    Askelöf P, Rodmalm K, Wrangsell G, Larsson U, Svenson SB, Cowell JL, Undén A, Bartfai T.
    Dev Biol Stand; 1991 Feb 17; 73():111-20. PubMed ID: 1778305
    [Abstract] [Full Text] [Related]

  • 28. Further characterization of Japanese acellular pertussis vaccine prepared in 1988 by 6 Japanese manufacturers.
    Sato Y, Sato H.
    Tokai J Exp Clin Med; 1988 Feb 17; 13 Suppl():79-88. PubMed ID: 2908530
    [Abstract] [Full Text] [Related]

  • 29. Comparison of the protective effects of the pertussis acellular vaccine with the component vaccine, which have different amounts of fimbriae, against the experimental aerosol infection of mice with Bordetella pertussis.
    Morokuma K, Ginnaga A, Nishihara T, Tsunoda S, Furukawa M, Aihara K, Sakoh M.
    Dev Biol Stand; 1991 Feb 17; 73():223-32. PubMed ID: 1685713
    [Abstract] [Full Text] [Related]

  • 30. Mouse and pig models for studies of natural and vaccine-induced immunity to Bordetella pertussis.
    Mills KH, Gerdts V.
    J Infect Dis; 2014 Apr 01; 209 Suppl 1():S16-9. PubMed ID: 24626866
    [Abstract] [Full Text] [Related]

  • 31. Role of pertactin in pertussis vaccines: the jury is still out.
    Desauziers E, Danve B, Decker MD, Veitch K.
    J Infect Dis; 2004 Apr 01; 189(7):1332-3; author reply 1333-5. PubMed ID: 15031804
    [No Abstract] [Full Text] [Related]

  • 32. Mouse-protecting and histamine-sensitizing activities of pertussigen and fimbrial hemagglutinin from Bordetella pertussis.
    Munoz JJ, Arai H, Cole RL.
    Infect Immun; 1981 Apr 01; 32(1):243-50. PubMed ID: 6260681
    [Abstract] [Full Text] [Related]

  • 33. Pathogenesis and histopathology of pertussis: implications for immunization.
    Cherry JD, Paddock CD.
    Expert Rev Vaccines; 2014 Sep 01; 13(9):1115-23. PubMed ID: 24992986
    [Abstract] [Full Text] [Related]

  • 34. Pertussis encephalopathy with a normal brain biopsy and elevated lymphocytosis-promoting factor antibodies.
    Davis LE, Burstyn DG, Manclark CR.
    Pediatr Infect Dis; 1984 Sep 01; 3(5):448-51. PubMed ID: 6093068
    [No Abstract] [Full Text] [Related]

  • 35. Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccine.
    Taranger J, Trollfors B, Bergfors E, Knutsson N, Lagergård T, Schneerson R, Robbins JB.
    Pediatrics; 2001 Dec 01; 108(6):E115. PubMed ID: 11731642
    [Abstract] [Full Text] [Related]

  • 36. Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains.
    Bottero D, Gaillard ME, Fingermann M, Weltman G, Fernández J, Sisti F, Graieb A, Roberts R, Rico O, Ríos G, Regueira M, Binsztein N, Hozbor D.
    Clin Vaccine Immunol; 2007 Nov 01; 14(11):1490-8. PubMed ID: 17699837
    [Abstract] [Full Text] [Related]

  • 37. Antigens of Bordetella pertussis. IV. Effect of heat, merthiolate, and formaldehyde on histamine-sensitizing factor and protective activity of soluble extracts from Bordetella pertussi.s.
    Munoz J, Hestekin BM.
    J Bacteriol; 1966 Jun 01; 91(6):2175-9. PubMed ID: 4287581
    [Abstract] [Full Text] [Related]

  • 38. Studies on culture conditions of Bordetella pertussis and relationship to immunogenicity of vaccines.
    Bellalou J, Relyveld EH.
    Ann Microbiol (Paris); 1984 Jun 01; 135B(1):101-10. PubMed ID: 6095715
    [Abstract] [Full Text] [Related]

  • 39. Binding of murine antibodies against whole-cell pertussis vaccine or filamentous haemagglutinin by Bordetella pertussis from patients with whooping cough.
    van den Berg BM, Beekhuizen H, Van Furth R, Mooi FR.
    Scand J Immunol; 2000 May 01; 51(5):530-2. PubMed ID: 10792847
    [Abstract] [Full Text] [Related]

  • 40. The detoxification of Bordetella pertussis with glutaraldehyde.
    Iida T, Horiuchi Y.
    J Biol Stand; 1987 Jan 01; 15(1):17-26. PubMed ID: 2881932
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.